(Q35191590)

7 August 2017

Pharmacokinetics and virological efficacy after switch to once-daily lopinavir-ritonavir in treatment-experienced HIV-1-infected children (English)

1 reference

7 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

2

Saïk Urien

0 references

Jean-Marc Tréluyer

6

object named as

Jean-Marc Treluyer

0 references

author name string

Frantz Foissac

1

1 reference

7 August 2017

Saïk Urien

2

1 reference

7 August 2017

Déborah Hirt

3

1 reference

7 August 2017

Pierre Frange

4

1 reference

7 August 2017

Marie-Laure Chaix

5

1 reference

7 August 2017

Jean-Marc Treluyer

6

1 reference

7 August 2017

Stéphane Blanche

7

1 reference

7 August 2017

language of work or name

English

0 references

publication date

11 July 2011

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

1 reference

7 August 2017

55

1 reference

7 August 2017

9

1 reference

7 August 2017

4320-4325

1 reference

Population pharmacokinetics of lopinavir predict suboptimal therapeutic concentrations in treatment-experienced human immunodeficiency virus-infected children

7 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Mechanism-based concepts of size and maturity in pharmacokinetics

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Population analysis of weight-, age-, and sex-related differences in the pharmacokinetics of lopinavir in children from birth to 18 years

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Pharmacokinetics and tolerability of once- versus twice-daily lopinavir/ritonavir treatment in HIV-1-infected children.

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Pharmacokinetics of lopinavir in HIV type-1-infected children taking the new tablet formulation once daily

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Lopinavir/Ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3165353

Lopinavir/ritonavir: a review of its use in the management of HIV infection

27 September 2018

1 reference

12 December 2020

Lopinavir/ritonavir exposure in treatment-naive HIV-infected children following twice or once daily administration

1 reference

12 December 2020

Pharmacokinetics of a once-daily regimen of lopinavir/ritonavir in HIV-1-infected children

1 reference

12 December 2020

A once-daily lopinavir/ritonavir-based regimen provides noninferior antiviral activity compared with a twice-daily regimen

1 reference

12 December 2020

High-dose lopinavir/ritonavir in highly treatment-experienced HIV-1 patients: efficacy, safety, and predictors of response

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.00166-11

1 reference

7 August 2017

1 reference

7 August 2017

1 reference